JPM

242.09

-0.08%↓

AXP

264.69

+0.02%↑

RY

116.82

+0.22%↑

MMC

215.29

-0.92%↓

TD

61.92

+0.15%↑

JPM

242.09

-0.08%↓

AXP

264.69

+0.02%↑

RY

116.82

+0.22%↑

MMC

215.29

-0.92%↓

TD

61.92

+0.15%↑

JPM

242.09

-0.08%↓

AXP

264.69

+0.02%↑

RY

116.82

+0.22%↑

MMC

215.29

-0.92%↓

TD

61.92

+0.15%↑

JPM

242.09

-0.08%↓

AXP

264.69

+0.02%↑

RY

116.82

+0.22%↑

MMC

215.29

-0.92%↓

TD

61.92

+0.15%↑

JPM

242.09

-0.08%↓

AXP

264.69

+0.02%↑

RY

116.82

+0.22%↑

MMC

215.29

-0.92%↓

TD

61.92

+0.15%↑

KKR & Co LP

Отворен

СекторФинансови

113.27 0.24

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

111.62

Максимум

114.01

Ключови измерители

By Trading Economics

Приходи

784M

1.4B

Продажби

-1.5B

3.2B

P/E

Средно за сектора

29.863

20.525

EPS

1.32

Дивидентна доходност

0.71

Марж на печалбата

43.254

Служители

4,834

EBITDA

45M

2.5B

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+31.54% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

0.71%

4.36%

Следващи печалби

1.05.2025 г.

Следваща дата на екс-дивидент

12.05.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-26B

95B

Предишно отваряне

113.03

Предишно затваряне

113.27

Техническа оценка

By Trading Central

Увереност

Very Strong Bullish Evidence

KKR & Co LP Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

22.04.2025 г., 06:50 ч. UTC

Придобивния, сливания и поглъщания

KKR Launches $1.2 Billion Takeover Bid For Swedish Life-Sciences Company Biotage

14.04.2025 г., 11:46 ч. UTC

Придобивния, сливания и поглъщания

CME Group, S&P Group Agree to Sell OSTTRA to KKR in $3.1 Billion Deal

9.04.2025 г., 10:24 ч. UTC

Придобивния, сливания и поглъщания

EQT to Sell Karo Healthcare to KKR

9.04.2025 г., 07:09 ч. UTC

Придобивния, сливания и поглъщания

Assura Accepts $2 Billion Takeover Offer From KKR Consortium

9.04.2025 г., 06:02 ч. UTC

Придобивния, сливания и поглъщания

KKR Nears $2.85 Billion Deal With EQT For E45 Maker Karo Healthcare, FT Reports, Citing Sources

7.04.2025 г., 14:42 ч. UTC

Придобивния, сливания и поглъщания

Assura Agrees to Primary Health Properties Bid Deadline Extension

4.04.2025 г., 10:15 ч. UTC

Значими двигатели на пазара
Придобивния, сливания и поглъщания

Gerresheimer Shares Fall After Report That KKR Exited Consortium Seeking Bid

4.04.2025 г., 09:39 ч. UTC

Придобивния, сливания и поглъщания

KKR Drops Out of Consortium Attempting Gerresheimer Takeover, Bloomberg Says, Citing Sources

3.04.2025 г., 14:57 ч. UTC

Придобивния, сливания и поглъщания

Primary Health Proposes $1.95 Billion Bid for Assura -- Update

3.04.2025 г., 07:17 ч. UTC

Придобивния, сливания и поглъщания

Primary Health Proposes $1.95 Billion Bid for Assura

22.04.2025 г., 06:04 ч. UTC

Придобивния, сливания и поглъщания

KKR: Offer Price Represents 60% Premium to Thursday's Closing Price

22.04.2025 г., 06:03 ч. UTC

Придобивния, сливания и поглъщания

KKR: Biotage Board Recommends Shareholders Accept Offer

22.04.2025 г., 06:02 ч. UTC

Придобивния, сливания и поглъщания

KKR: Offer Values Biotage at SEK11.61B

22.04.2025 г., 06:02 ч. UTC

Придобивния, сливания и поглъщания

KKR Makes SEK145 a Share Bid For Biotage

18.04.2025 г., 00:00 ч. UTC

Топ новини

Private Equity World Engulfed by Perfect Storm -- WSJ

14.04.2025 г., 11:31 ч. UTC

Топ новини
Придобивния, сливания и поглъщания

CME Group, S&P Group Agree to Sell OSTTRA to KKR in $3.1B Deal

14.04.2025 г., 11:02 ч. UTC

Придобивния, сливания и поглъщания

KKR: Making OSTTRA Investment Primarily Through North America Private-Equity Strategy >KKR

14.04.2025 г., 11:01 ч. UTC

Придобивния, сливания и поглъщания

S&P Global, CME to Divide Sale Proceeds Evenly Pursuant to 50/50 Joint Venture >SPGI CME

14.04.2025 г., 11:00 ч. UTC

Придобивния, сливания и поглъщания

S&P Global, CME Group to Sell OSTTRA to KKR for $3.1 Billion >SPGI CME KKR

14.04.2025 г., 11:00 ч. UTC

Придобивния, сливания и поглъщания

S&P Global and CME Group to Sell OSTTRA to KKR for $3.1 Billion

11.04.2025 г., 11:56 ч. UTC

Придобивния, сливания и поглъщания

KKR Now Owns 30% of Enilive

11.04.2025 г., 11:55 ч. UTC

Придобивния, сливания и поглъщания

KKR Completes Acquisition of Additional Stake in Enilive

9.04.2025 г., 09:51 ч. UTC

Придобивния, сливания и поглъщания

EQT to Sell Karo Healthcare to KKR for an Undisclosed Amount

9.04.2025 г., 09:32 ч. UTC

Придобивния, сливания и поглъщания

EQT: Transaction Expected to Close in Coming Months

9.04.2025 г., 09:31 ч. UTC

Придобивния, сливания и поглъщания

EQT to Sell Karo Healthcare to KKR

3.04.2025 г., 08:17 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Primary Health Properties' Lower Bid for Assura Is a Calculated Risk -- Market Talk

28.03.2025 г., 09:34 ч. UTC

Придобивния, сливания и поглъщания

Topcon: Tender Offer Expected to Start Around End-July >7732.TO

28.03.2025 г., 09:33 ч. UTC

Придобивния, сливания и поглъщания

Topcon: CEO Takashi Eto Also Plans to Participate in Tender Offer, Make Reinvestment After Completion of Offer >7732.TO

28.03.2025 г., 09:31 ч. UTC

Придобивния, сливания и поглъщания

Topcon: JICC Plans to Indirectly Hold Voting Rights in Topcon >7732.TO

28.03.2025 г., 09:31 ч. UTC

Придобивния, сливания и поглъщания

Topcon: KKR Plans to Indirectly Hold Majority Interest in Topcon >7732.TO

Сравнение с други в отрасъла

Ценова промяна

KKR & Co LP Прогноза

Ценова цел

By TipRanks

31.54% нагоре

12-месечна прогноза

Среден 140.5 USD  31.54%

Висок 194 USD

Нисък 114 USD

Според 12 анализатори от Wall Street, предложили 12-месечна ценова цел за KKR & Co LP през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

12 ratings

11

Купи

1

Задържане

0

Продай

Техническа оценка

By Trading Central

101.87 / N/AПодкрепа & съпротива

Краткосрочен план

Very Strong Bullish Evidence

Средносрочен план

Bearish Evidence

Дългосрочен план

Weak Bearish Evidence

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно KKR & Co LP

KKR & Co. Inc. is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market, and middle market investments. The firm considers investments in all industries with a focus on software, security, semiconductors, consumer electronics, internet of things (iot), internet, information services, information technology infrastructure, financial technology, network and cyber security architecture, engineering and operations, content, technology and hardware, energy and infrastructure, real estate, services industry with a focus on business services, intelligence, industry-leading franchises and companies in natural resource, containers and packaging, agriculture, airports, ports, forestry, electric utilities, textiles, apparel and luxury goods, household durables, digital media, insurance, brokerage houses, non-durable goods distribution, supermarket retailing, grocery stores, food, beverage, and tobacco, hospitals, entertainment venues and production companies, publishing, printing services, capital goods, financial services, specialized finance, pipelines, and renewable energy. In energy and infrastructure, it focuses on the upstream oil and gas and equipment, minerals and royalties and services verticals. In real estate, the firm seeks to invest in private and public real estate securities including property-level equity, debt and special situations transactions and businesses with significant real estate holdings, and oil and natural gas properties. The firm also invests in asset services sector that encompasses a broad array of B2B, B2C and B2G services verticals including asset-based, transport, logistics, leisure/hospitality, resource and utility support, infra-like, mission-critical, and environmental services. Within Americas, the firm prefers to invest in consumer products; chemicals, metals and m